Diarrhea, Infantile Clinical Trial
Official title:
Efficacy and Safety of Racecadotril in the Treatment of Taiwanese Children Aged 3 to 60 Months Suffering From Acute Diarrhea: A Prospective, Open-label, Multicenter, Single-arm Study.
This is a prospective, open-label, multicenter, single-arm study evaluating the efficacy and safety of Racecadotril the treatment of children aged 3 to 60 months suffering from acute diarrhea
Subjects presenting with acute diarrhea will be evaluated for eligibility. If eligible, demographics, number of stools during the last 12 hours will be assessed as baseline values. On Day 1, the subject will start with study treatment. Subjects will be treated with Racecadotril three times daily according to the body weight dose requirement on an out-patient basis for maximum 5 days in addition to ORS. ORS will be prescribed by the investigator. The parent(s)/caregiver(s)/legal representative(s) will be instructed to stop treatment when the patient recovered. Recovery is defined by the evacuation of the first of two consecutive normal stools or no stool within 12 hours. In the evening of each day, the parent(s)/caregiver(s)/legal representative(s) will fill in their diaries, documenting date and time of each individual stool, the stool consistency of each stool, ORS amount and the study drug intake. AEs are to be reported on an ongoing basis. The last dose of study drug intake will be the morning dose of day 6, if not recovered earlier. The parent(s)/caregiver(s)/legal representative(s) will visit the site for the end of study visit of the child. Data on vital signs, AEs, physical examination and concomitant medication will be collected. The parent(s)/caregiver(s)/legal representative(s) will return the diaries and unused medication. A phone call contact will be performed 5-7 days after the end of the treatment period or recovery for the safety follow-up. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00732732 -
A Controlled Trial of Plantain Powder in Infantile Diarrhea
|
N/A | |
| Not yet recruiting |
NCT03598010 -
Safety, Tolerability and Preliminary Efficacy of Lenodiar Pediatric in Diarrhea
|
N/A | |
| Recruiting |
NCT04654832 -
IVC Index in Patient With Diarrhea and Dehydration And How It Affects Its Management
|
||
| Completed |
NCT04061538 -
Efficiency and Safety of Zinc Sulphate to Reduce the Duration of Acute Diarrheal Disease Between 6 and 59 Months of Age
|
N/A | |
| Completed |
NCT05322655 -
PAthogen Transmission and Health Outcome Models of Enteric Disease
|
||
| Recruiting |
NCT02870751 -
Human Challenge Model With ST-only Enterotoxigenic Escherichia Coli
|
Phase 1 | |
| Completed |
NCT01345695 -
Bihar Evaluation of Social Franchising and Telemedicine
|
N/A | |
| Recruiting |
NCT04528303 -
Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and Enteropahty
|
N/A | |
| Completed |
NCT04335877 -
Effect of Prompting the Supply of Zinc/LO-ORS Co-packs in the Private Sector Plus BCI on Childhood Diarrhea Treatment
|
N/A | |
| Active, not recruiting |
NCT03012048 -
Effectiveness of Point-of-use Water Treatment Technologies to Prevent Stunting Among Children in South Africa
|
N/A | |
| Completed |
NCT04677296 -
Efficacy and Safety of "VS002A" With the Standard WHO-ORS in Non-cholera Acute Watery Diarrhea in Infants and Young Children
|
N/A | |
| Completed |
NCT04209751 -
Descriptive Study of Pathogens Involved in Summer Diarrhea in Children Leading to Pediatric Emergency Room Visits (PE-DIA)
|
||
| Completed |
NCT00447161 -
Preventing Antibiotic-Associated DiarRhea Using Erceflora
|
Phase 4 | |
| Recruiting |
NCT05766826 -
Coupons for Safe Water Project
|
N/A | |
| Terminated |
NCT04628819 -
Effect and Tolerability of Lactobacillus Rhamnosus GG LA801 for the Preventive Nutritional Care of Nosocomial Diarrhea in Children
|
N/A |